Protein Phosphatase-1 (PP-1) appears to be the key component of the in
sulin signalling pathway which is responsible for bridging the initial
insulin-simulated phosphorylation cascade with the ultimate dephospho
rylation of insulin sensitive substrates. Dephosphorylations catalyzed
by PP-1 activate glycogen synthase (GS) and simultaneously inactivate
phosphorylase a and phosphorylase kinase promoting glycogen synthesis
. Our in vivo studies using L6 rat skeletal muscle cells and freshly i
solated adipocytes indicate that insulin stimulates PP-1 by increasing
the phosphorylation status of its regulatory subunit (PP-1(G)). PP-1
activation is accompanied by an inactivation of Protein Phosphatase-2A
(PP-2A) activity. To gain insight into the upstream kinases that medi
ate insulin-stimulated PP-1(G) phosphorylation, we employed inhibitors
of the ras/MAPK, PI3-kinase, and PKC signalling pathways. These inhib
itor studies suggest that PP-1, phosphorylation is mediated via a comp
lex, cell type specific mechanism involving PI3-kinase/PKC/PKB and/or
the ras/MAP kinase/Rsk kinase cascade. CAMP agonists such as SpcAMP (v
ia PKA) and TNF-alpha (recently identified as endogenous inhibitor of
insulin action via ceramide) block insulin-stimulated PP-1(G) phosphor
ylation with a parallel decrease of PP-1 activity, presumably due to t
he dissociation of the PP-1 catalytic subunit from the regulatory G-su
bunit. It appears that any agent or condition which interferes with th
e insulin-induced phosphorylation and activation of PP-1, will decreas
e the magnitude of insulin's effect on downstream metabolic processes.
Therefore, regulation of the PP-1(G) subunit by site-specific phospho
rylation plays an important role in insulin signal transduction in tar
get cells. Mechanistic and functional studies with cell lines expressi
ng PP-1(G) subunit site-specific mutations will help clarify the exact
role and regulation of PP-1(G) site-specific phosphorylations on PP-1
catalytic function.